Meanwhile, the migrative and invasive ability of breast cancer cells treated with ASOs was significantly boosted (Figure 6B), further suggesting that RBM7-knockdown stimulated aggressiveness of breast cancer at least partially relies on the control of MFGE8 AS. This evidence concerns the gene MFGE8 and breast carcinoma.